Circulating binding proteins for the insulinlike growth factors

Trends in Endocrinology and Metabolism

Volumn 4, Issue 3, 1993, Pages 91-96

  Baxter, Robert C ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GLYCOPROTEIN; GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

BINDING AFFINITY; CIRCADIAN RHYTHM; GLUCOSE HOMEOSTASIS; GROWTH HORMONE DEFICIENCY; HUMAN; METABOLIC REGULATION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; SHORT SURVEY;

EID: 0027262380     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/1043-2760(93)90085-S     Document Type: Review

References (51)

1. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP2 and endothelial cell IGF-binding proteins in the rat heart
2. Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin like growth factorbinding proteins in the rat heart
3. Circulating levels and molecular distribution of the acid-labile (a) subunit of the high molecular weight insulinlike growth factor-binding protein complex
4. Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma
5. Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors
6. Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma
7. Binding proteins for the insulin-like growth factors: structure, regulation and function
8. Radioimmunoassay of insulin-like growth factorbinding protein-6 in human serum and other body fluids
9. High molecular weight insulin-like growth factor binding protein complex: purification and properties of the acid-labile subunit from human serum
10. Responses of insulin-like growth factor binding protein-1 (IGFBP-1) and the IGFBP-3 complex to administration of insulin-like growth factor-I
11. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedinbinding protein: its use for diagnosis of GH deficiency
12. Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I
13. Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion
14. Insulinlike growth factor binding proteins
15. Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin
16. Variables controlling the secretion of insulinlike growth factor-binding protein-2 in normal human subjects
17. Regulation of the growth hormone-independent growth factor-binding protein in children
18. Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery
19. The induction of a specific protease for insulin-like growth factor-binding protein3 in the circulation during severe illness
20. Structural aspects of the IGFBP family
21. Most of the circulating insulin-like growth factors-I and -II are present in the 150 kD complex during human pregnancy
22. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity
23. Serum levels of the low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly and anorexia nervosa
24. The physiological role of IGFBP-1
25. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy
26. Identification and molecular cloning of two new 30-kD insulin-like growth factor binding proteins isolated from adult human serum
27. Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid
28. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously
29. Insulin-like growth factor-binding protein-1: a role in glucose counterregulation?
30. Insulin-like growth factorbinding protein-1 modulates blood glucose levels
31. Distribution and actions of human IGFBP-1 and IGFBP-3 in the rat
32. Production of an insulin-like growth factor (IGF)-inducible IGF-binding protein by human skin fibroblasts
33. Insulin-like growth factor binding protein-3: biochemistry and physiology
34. Insulinlike growth factor binding protein expression in the hypothyroid rat is age dependent
35. Insulin-like growth factor binding proteins: gene structure and expression
36. Isolation from human cerebrospinal fluid of a new insulin-like growth factor-binding protein with a selective affinity for IGF-II
37. The 24/25-kD serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures
38. Radioimmunoassay of placental protein 12: levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease
39. Insulindependent regulation of insulin-like growth factor-binding protein-1
40. Insulin-like growth factor (IGF) binding protein-3 in pregnancy serum binds native IGF-I but not iodo-IGF-1
41. Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum
42. Structural regions in IGF-I which determine differential binding to IGFBP-3 from nonpregnancy serum
43. Circulating levels of immunoreactive insulin-like growth factor-binding protein in non-pregnant women
44. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein
45. Short and long term effects of growth hormone on circulating levels of insulinlike growth factor-I (IGF-I), IGF-binding protein-1, and insulin: a placebo-controlled study
46. Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through an adenosine 3′,5′-monophosphate-dependent mechanism
47. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGFbinding proteins in calorically restricted adults
48. Determination of the pharmacokinetic profiles of insulin-like growth factor binding proteins-1 and -2 in rats
49. Recombinant human insulin-like growth factor-I induced its own specific carrier protein in hypophysectomized and diabetic rats
50. Regulation of binding proteins for insulinlike growth factors (IGFs) in humans
51. Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF I administration and in extrapancreatic tumor hypoglycemia